Amyloidosis: is a cure possible?

被引：54
作者：
Merlini, G. [1 ]
Palladini, G. [1 ]
机构：
[1] Univ Pavia, Fdn IRCCS Policlin San Matteo, Amyloidosis Ctr, I-27100 Pavia, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
10.1093/annonc/mdn200
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：63 / 66
页数：4
相关论文
共 15 条
[1]   Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis:: results of a phase II trial [J].
Cohen, Adam D. ;
Zhou, Ping ;
Chou, Joanne ;
Teruya-Feldstein, Julie ;
Reich, Lilian ;
Hassoun, Hani ;
Levine, Beth ;
Filippa, Daniel A. ;
Riedel, Elyn ;
Kewalramani, Tarun ;
Stubblefield, Michael D. ;
Fleisher, Martin ;
Nimer, Stephen ;
Comenzo, Raymond L. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (02) :224-233
[2]   Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628 [J].
Dhodapkar, MV ;
Hussein, MA ;
Rasmussen, E ;
Solomon, A ;
Larson, RA ;
Crowley, JJ ;
Barlogie, B .
BLOOD, 2004, 104 (12) :3520-3526
[3]   Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis [J].
Dispenzieri, A ;
Gertz, MA ;
Kyle, RA ;
Lacy, MQ ;
Burritt, MF ;
Therneau, TM ;
Greipp, PR ;
Witzig, TE ;
Lust, JA ;
Rajkumar, SV ;
Fonseca, R ;
Zeldenrust, SR ;
McGregor, CGA ;
Jaffe, AS .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3751-3757
[4]   The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis [J].
Dispenzieri, Angela ;
Lacy, Martha Q. ;
Zeldenrust, Steven R. ;
Hayman, Suzanne R. ;
Kumar, Shaji K. ;
Geyer, Susan M. ;
Lust, John A. ;
Allred, Jacob B. ;
Witzig, Thomas E. ;
Rajkumar, S. Vincent ;
Greipp, Philip R. ;
Russell, Stephen J. ;
Kabat, Brian ;
Gertz, Morie A. .
BLOOD, 2007, 109 (02) :465-470
[5]   Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate [J].
Gertz, MA ;
Lacy, MQ ;
Dispenzieri, A ;
Ansell, SM ;
Elliott, MA ;
Gastineau, DA ;
Inwards, DJ ;
Micallef, INM ;
Porrata, LF ;
Tefferi, A ;
Litzow, MR .
BONE MARROW TRANSPLANTATION, 2004, 34 (12) :1025-1031
[6]   Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response [J].
Gertz, Morie A. ;
Lacy, Martha Q. ;
Dispenzieri, Angela ;
Hayman, Suzanne R. ;
Kumar, Shaji K. ;
Leung, Nelson ;
Gastineau, Dennis A. .
HAEMATOLOGICA, 2007, 92 (10) :1415-1418
[7]   High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis [J].
Jaccard, Arnaud ;
Moreau, Philippe ;
Leblond, Veronique ;
Leleu, Xavier ;
Benboubker, Lotfi ;
Hermine, Olivier ;
Recher, Christian ;
Asli, Bouchra ;
Lioure, Bruno ;
Royer, Bruno ;
Jardin, Fabrice ;
Bridoux, Frank ;
Grosbois, Bernard ;
Jaubert, Jerome ;
Piette, Jean-Charles ;
Ronco, Pierre ;
Quet, Fabrice ;
Cogne, Michel ;
Fermand, Jean-Paul .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (11) :1083-1093
[8]   Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone [J].
Kastritis, Efstathios ;
Anagnostopoulos, Athanasios ;
Roussou, Maria ;
Toumanidis, Savvas ;
Pamboukas, Constantinos ;
Migkou, Magdalini ;
Tassidou, Anna ;
Xilouri, Irini ;
Delibasi, Sossana ;
Psimenou, Erasmia ;
Mellou, Sofia ;
Terpos, Evangelos ;
Nanas, John ;
Dimopoulos, Meletios A. .
HAEMATOLOGICA, 2007, 92 (10) :1351-1358
[9]   A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine [J].
Kyle, RA ;
Gertz, MA ;
Greipp, PR ;
Witzig, TE ;
Lust, JA ;
Lacy, MQ ;
Therneau, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (17) :1202-1207
[10]   Dangerous small B-cell clones [J].
Merlini, Giampaolo ;
Stone, Marvin J. .
BLOOD, 2006, 108 (08) :2520-2530
12